Subsection 3: National master plan for blood transfusion organisation and regional blood transfusion organisation plans

The national blood transfusion master plan referred to in article L. 1222-15 is prepared by the Etablissement Français du Sang. It is approved by the Minister for Health, after consultation with the Minister for Defence and the National Steering Council for Regional Health Agencies referred to in article L. 1433-1. The council gives its opinion within two months of receiving the draft plan from the Etablissement Français du Sang. The…

The President of the Etablissement Français du Sang draws up, in compliance with the national master plan mentioned in article L. 1222-15, the regional blood transfusion organisation plans, which specify the procedures for carrying out the blood transfusion activities of the Etablissement Français du Sang in conjunction with health establishments. Each regional blood transfusion organisation plan determines : 1° The fixed collection sites ; 2° Technical facilities for the biological…

The territorial jurisdiction of each regional blood transfusion organisation plan is determined by the President of the Etablissement Français du Sang. Each regional blood transfusion organisation plan is drawn up for a period of five years.

The President of the Etablissement Français du Sang submits the draft regional plan for an opinion, by any means which confers a date of receipt, to each regional health agency concerned and to the Minister for Health, as well as, where an army hospital or other element of the army health service is concerned, to the Minister for Defence. The opinions of the Regional Health Agency, the Minister for Health…

Regional plans may be amended or repealed by decision of the President of the Etablissement Français du Sang in accordance with the procedure set out in Article R. 1222-50. However, the opinion of the Regional Health Agency is not required for amendments to the plans relating to fixed collection sites, technical facilities for the preparation of labile blood products and technical facilities for the biological qualification of donations.

The provisions of this sub-section do not apply to the Armed Forces Blood Transfusion Centre, subject to the provisions of articles R. 1222-47, R. 1222-50 and R. 1222-51.